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Summary. Eukaryotic ells live in a relatively comfortable equilib- 
rium with a wide variety of microbes. However, while many of the 
cohabiting microorganisms are harmless or even beneficial to the 
eukaryotic host, a number of prokaryotes have evolved the capac- 
ity to invade and replicate within host cells, thereby becoming 
potentially pathogenic. Tobe able to cope with potential pathogens, 
most organisms have developed several host defense mechanisms. 
First, microbes can be internalized and destroyed by a number of 
cell types of an innate immune system in a rather aspecific manner. 
Second, more complex organisms possess additionally an adaptive 
immune system that is capable of eliminating hazardous microbes 
in a highly specific manner. This review describes recent progress 
in our understanding of how pathogens interact with cells of the 
immune system, resulting inactivation ofthe immune system or, for 
certain microorganisms, in the evasion of host defense reactions. 
Keywords: Antigen processing; Antigen presentation; Phagocytosis; 
Host defense subversion. 
Introduction 
In the fight against microbes, various types of host 
responses occur, which fall into two classes. First, 
several nonspecific host defense mechanisms exist 
(innate immune response), and second, the host pos- 
sesses various mechanisms that are directed at a par- 
ticular invader (adaptive immunity). Under normal 
circumstances, the first line of defense is provided by 
the cells of the innate immune system, the macro- 
phages, neutrophils, dendritic cells, and natural killer 
cells. These cells are attracted to the site of infection 
through multiple stimuli; macrophages and neu- 
trophils accumulate at these sites in response to bac- 
terial products, while cytokines ecreted by these cells 
attract more macrophages and neutrophils as well 
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as dendritic cells and natural killer cells. The innate 
immune system ensures an effective response by 
efficiently degrading the microbes (antigens) either 
through intracellular proteolysis following uptake or 
via the release of degradative nzymes after release 
of their granule content (Brown et al. 1994, Janeway 
1989). 
A more specialized response to invading pathogens 
is provided by cells of the adaptive immune system, 
comprising the B ceils (originating in the bone 
marrow, hence the name B lymphocytes) and the T 
cells (originating in the thymus, therefore termed T 
lymphocytes). Importantly, activation of T lympho- 
cytes depends on the recognition by the T cell recep- 
tors of peptides derived from pathogenic organisms. 
These peptides are not recognized alone, but in a 
complex with specialized molecules, the class I and 
class II molecules encoded by the major histocompat- 
ibility complex (MHC) (Zinkernagel 1997). 
Presentation of microbial antigens 
to the immune system 
The two classes of peptide presenting molecules 
(MHC class I and class II molecules) have probably 
evolved as a result of the existence of two types of 
pathogens that can invade the eukaryotic ell. One 
type, such as viruses, occupies the cytoplasmic om- 
partment, and viral peptides are presented by MHC 
class I molecules. The other type, most extracellularly 
residing bacteria, enters the endosomal-lysosomal 
organelles, and bacteria-derived antigens are being 
presented by MHC class II molecules. An overview of 
the MHC class I and class II pathways is provided in 
Fig. 1. 
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Fig. la,  b. The MHC class I and class II pathways, a MHC class I 
molecules acquire antigenic peptides that are generated from infec- 
tious agents residing in the cytosol of infected cells (by, e.g., viruses). 
These peptides are formed by the proteasome and then translocated 
into the endoplasmic reticulum by the TAP complex. The MHC 
class I-peptide complex is transported through the biosynthetic 
pathway directly to the plasma membrane, for the activation of 
CD8 § T lymphocytes, b Peptides to be presented by MHC class II 
molecules are usually derived from antigens that are present extra- 
cellularly (such as most bacteria). This extracellularly residing mate- 
rial enters the cell through endocytosis or phagocytosis and is 
degraded within endosomal-lysosomal organelles. The resulting 
peptides are loaded onto MHC class II molecules in specialized 
organelles, the so-called MHC class II compartments, prior to trans- 
port of the class II-peptide complex to the cell surface for trigger- 
ing of CD4 § T helper lymphocytes ( ee also Janeway and Travers 
1996) 
Both MHC class I and class II molecules, being 
transmembrane molecules, are synthesized on endo- 
plasmic-reticulum-associated ribosomes and cotrans- 
lationally inserted in the endoplasmic-reticulum mem- 
brane (Dobberstein et al. 1979, Ploegh et al. 1979). 
The MHC-encoded molecules are generally highly 
polymorphic, ensuring that a wide variety of different 
peptides can be presented by these molecules (Be- 
nacerraf and McDevitt 1972, Kaufman et al. 1984, 
Mengle-Gaw and McDevitt 1985, Snell 1986, Trows- 
dale and Campbell 1992). 
MHC class I pathway 
MHC class I molecules are expressed by all cells and 
associate in the endoplasmic reticulum with another 
molecule, [3-2-microglobulin (Heemels and Ploegh 
1995). Proteins derived from viruses and bacteria that 
reside in the cytosol are degraded by the cytosolic pro- 
teolytic machinery, the proteasome, and the resulting 
peptides are transported into the endoplasmic reticu- 
lure by transporter molecules, the TAP molecules 
(transporter associated with antigen processing) (Dev- 
erson et al. 1990, Spies et al. 1990). MHC class I mole- 
cules become loaded with antigenic peptides in the 
endoplasmic reticulum and are then transported via 
the secretory pathway through the Golgi complex to 
the cell surface where they can be recognized by a 
subset of T lymphocytes, the cytotoxic T cells (Pamer 
and Cresswell 1998, Townsend et al. 1989). Triggering 
of T cell receptors on cytotoxic T cells usually results 
in the death of the antigen-presenting cell, thus effec- 
tively eliminating the source of the infection (see 
Fig. 1). 
MHC class H pathway 
Class II molecules, in contrast o MHC class I mole- 
cules, are expressed by only a subset of cells special- 
ized in the presentation of extracellularly present 
antigens, including B cells, macrophages, and dendritic 
cells. Peptides destined to be presented by class II 
molecules are usually derived from exogenous anti- 
gens. Therefore, deposition of peptide-loaded MHC 
class II molecules on the cell surface of antigen- 
presenting cells involves not only organelles of the 
secretory pathway but also of the endocytic pathway 
(Pieters 1999a, Wolf and Ploegh 1995). 
During the past decade, work from a variety of 
laboratories has delineated the pathways followed by 
MHC class II complexes. Directly after biosynthesis 
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and insertion into the membrane of endoplasmic re- 
ticulum, the class II molecules assemble noncovalently 
with a third molecule, the so-called invariant chain (Ii). 
In contrast o the class II molecules, the Ii is non- 
polymorphic and in fact encoded outside the MHC 
(Koch et al. 1989, Machamer and Cresswell 1982). The 
Ii performs three important functions during the 
biogenesis of surface-deposited class II molecules. 
First, the Ii acts as a chaperone in the endoplasmic 
reticulum, to aid in the folding and the egress of the 
class II/Ii complex from the endoplasmic reticulum 
(Anderson and Miller 1992). Second, the Ii contains 
a sequence (termed CLIR for class II-associated 
invariant-chain peptide) that binds directly to the class 
II peptide-binding groove, in a manner identical to 
antigenic peptides (Ghosh et al. 1995). In the endo- 
plasmic reticulum, the Ii therefore shields the class II 
peptide-binding roove from binding peptides that 
should, as mentioned above, bind to the MHC class I
molecules (Eynon et al. 1999, Roche and Cresswell 
1990, Teyton et al. 1990). 
Targeting of MHC class H molecules to 
the endocytic pathway 
The third important function of Ii is to provide a tar- 
geting signal for the class II molecules to be trans- 
ported to organelles of the endocytic pathway. Indeed, 
peptides destined to be presented by class II molecules 
are usually derived from exogenous antigens that 
have entered the endocytic pathway of the antigen- 
presenting cell (Cresswell 1994a, Pieters 1997b), and 
the molecule responsible for getting the class II com- 
plex into the endosomes i the associated invariant 
chain. The signals that are responsible for this target- 
ing event reside within the cytoplasmic tail and consist 
of two di-leucine-based motifs (Bakke and Dobber- 
stein 1990, Lotteau et al. 1990, Pieters et al. 1993). 
These signals mediate targeting of the class II com- 
plex from the trans-Golgi network to the endosomal 
pathway and, in addition, mediate the internalization 
of complexes that have arrived at the plasma mem- 
brane (Pieters et al. 1993). 
The MHC class H compartments 
Whereas initially the site where MHC class II mole- 
cules combine with antigenic peptides remained elu- 
sive, over the past few years the precise subcellular 
organelles to which class II/Ii complexes are targeted 
have been characterized relatively well. By immuno- 
cytochemistry on cryosections, it was shown that class 
II molecules, Ii as well as internalized material could 
be found within the same vesicles (Pieters et al. 1991). 
These organelles had a typical multivesicular mor- 
phology and were therefore referred to as multivesic- 
ular bodies (Pieters et al. 1991), or, because of their 
high class lI content, MHC class II compartments 
(Peters et al. 1991, Pieters 1997a). 
After the initial morphological identification of 
the MHC class II compartments, heir subsequent bio- 
chemical isolation from various cell types allowed 
their in-depth characterization (Amigorena et al. 1994, 
Tulp et al. 1994, West et al. 1994). This work established 
the class II compartments a distinct organelles, epa- 
rate from the endosomal-lysosomal p thway (Schmid 
and Jackson 1994). 
More recently, it was established that the MHC 
class II compartments actually consisted of two phy- 
sically and functionally distinct vesicle populations 
(Ferrari et al. 1997). Newly synthesized class II/li com- 
plexes travel through these organelles in a sequential 
manner: due to the endosomal targeting signals within 
the Ii cytoplasmic tail, the complex is first targeted to 
an organelle where the Ii is degraded from its C- 
terminal, lumenal side, resulting in a class II complex 
still associated with the CLIP peptide. The class II- 
CLIP complex, most likely due to a sorting signal 
within the class II molecules themselves, are then tar- 
geted to a second organelle, where CLIP is released 
from class II molecules. Interestingly, this latter com- 
partment contains the HLA-DM molecules, which 
function as facilitators of peptide loading onto class II 
molecules (Cresswell 1994b; Mellins et al. 1990; Roche 
1995, 1996). Indeed, peptides are readily loaded in this 
latter organelle, which therefore has been termed com- 
partment of peptide loading (CPL) (Ferrari et al. 1997, 
Pieters 1999a) (see also Fig. 1). From the compartment 
of peptide loading, peptide-loaded class II molecules 
travel to the cell surface by as yet undefined mecha- 
nisms, where they can trigger T cell receptors on T lym- 
phocytes leading to their activation. Activated T cells 
can then aid in the elimination of the invaded micro- 
organism, by either promoting production of specific 
antibodies by B cells or by activating phagocytic ells 
to more efficiently ingest and destroy microbes. 
Entry of microorganisms into eukaryotic ells 
Thus far we have discussed the mechanisms involved 
in the transfer of antigens to the MHC molecules that 
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present hese to the T lymphocytes of the immune 
system. But an important question is how these anti- 
gens end up in the appropriate cells. Extracellular 
pathogens, whose peptides are being presented by 
MHC class II molecules, usually enter the antigen- 
processing and -presenting cell via endocytosis. 
Several forms of endocytosis exist. First, soluble mate- 
rial (e.g., that released by the microbes) can enter 
the cell through pinocytosis ("cell drinking"; more 
recently renamed endocytosis), which is the vesicular 
uptake of fluid and macromolecules. Pinocytosis can 
be receptor mediated or occur via fluid-phase uptake, 
either in large ("macropinocytosis", .e. the uptake of 
fluid into large, 0.15-0.5 gm diameter vesicles) as well 
as in small (ca. 100 nm diameter) vesicles. In addition, 
professional ntigen-presenting cells such as the den- 
dritic cells and the macrophages have the capacity to 
internalize ntire microorganisms through the process 
of phagocytosis. Phagocytosis ("cell eating") refers to 
the internalization of large particles and microorgan- 
isms into large (_250 nm diameter) vesicles. 
The endocytic pathway 
Regardless of the mode of uptake, material that is 
internalized enters the endocytic pathway, is trans- 
ported from early to late endosomes, and may even- 
tually reach lysosomes (Kornfeld and Mellman 1989). 
The molecular mechanisms involved in transfer of 
material through the endosomal-lysosomal pathway is 
only beginning to be unraveled. Whereas the processes 
governing receptor-mediated uptake are now rela- 
tively well understood, those involved in phagocytosis 
and fluid-phase ndocytosis remain less well charac- 
terized and will be subject o review elsewhere in this 
series. Here, we will focus on the processes involved in 
entry and degradation of internalized microorganisms 
as well as microbial products. 
During receptor-mediated ndocytosis, receptors 
that are engaged by ligands can become clustered at 
the plasma membrane due to receptor cross-linking. 
During this process a scaffold protein, clathrin, is 
recruited to the cytoplasmic domain of the receptor 
and binds via a series of adaptor proteins that are spe- 
cific for certain signals residing within receptor cyto- 
plasmic portions (Kirchhausen et al. 1997, Pearse and 
Robinson 1990, Robinson 1994, Schmid 1997). The 
current model proposes that clathrin-containing coats 
initiate the plasma membrane invaginations contain- 
ing reeeptor-ligand complexes at the cytosolic side of 
the plasma membrane and aid in the formation of 
clathrin-coated vesicles from the plasma membrane 
(Kirchhausen 1999, Sever et al. 1999). These clathrin- 
coated vesicles are then uncoated, and their content 
is transferred to consecutive stages of the endocytic 
pathway (Schmid 1997). Recent work suggests that at 
several levels of the endocytic pathway, sorting events 
may occur that are dictated by the presence of specific 
sorting determinants, processes that may be regulated 
through various coat proteins (Stoorvogel et al. 1996, 
Whitney et al. 1995). Sorting of proteins within the 
endocytic pathway may lead to transport of proteins 
either back to the plasma membrane, to the trans- 
Golgi network, to late endosomes, or to lysosomes 
(Gu and Gruenberg 1999, Keller and Simons 1997, 
Kirchhausen et al. 1997). 
Phagocytosis 
Phagocytosis is defined as the internalization of entire 
microorganisms or relatively large particles rather 
than small molecular compounds. As a consequence, 
the mechanisms and machinery involved in these 
processes are likely to be distinct from those involved 
in endocytosis. During phagocytosis, relatively large 
pieces of the plasma membrane that surround the 
microorganism are internalized. Subsequently, this 
phagocytosed material has to be transferred to later 
stages of the endocytic pathway, followed by delivery 
to lysosomes (or formation of a so-called phagolyso- 
some through fusion of nascent phagosomes with lyso- 
somes) where this material can be degraded. 
A number of receptor molecules have been impli- 
cated in the internalization ofmicrobes by phagocytes 
and other cells. These include Fc receptors, mannose 
receptors, cavenging receptors, and various integrins 
(Brown 1991, Daeron 1997, Ezekowitz et al. 1991, 
Fanger et al. 1996). Furthermore, several microorgan- 
isms have developed sophisticated mechanisms togain 
entry into eukaryotic ells (Falkow 1991, Finlay and 
Cossart 1997). Some of these make use of host cell 
components, for example in the case of lysosome 
recruitment by trypanosomes (Tardieux et al. 1992), or 
express proteins that function as a bona fide receptor 
for a eukaryotic-cell surface component. Examples of 
these are the invasins expressed by Escherichia coli or 
Yersinia pseudotuberculosis and binding to integrins 
(Isberg and Leong 1990, Leong et al. 1995); internalin 
expressed by Listeria spp. and binding to E-cadherin 
(Mengaud et al. 1996); Tir expressed by enteropatho- 
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genic E. coIi (EPEC), which is directly inserted into 
the host plasma membrane (Kenny et al. 1997, Rosen- 
shine et al. 1996), and the type III secretion mecha- 
nisms present in, e.g., Salmonella spp., Shigella spp., 
and Yersinia spp., that generate a translocation system 
that is inserted into the host plasma membrane and 
interacts with the host cytoskeleton (Bliska et al. 1993, 
Cornelis 1998, Galan and Bliska 1996). Thus, it seems 
that many different pathways exist to internalize a 
microorganism into phagocytes; the precise mode of 
uptake may have evolved as a result of the long-term 
coevolution of microbes with phagocytic cells (Falkow 
1991). 
Macrophage activation 
One result of phagocytosis of particulate material 
as well as living microorganisms i  activation of the 
macrophages. Whether or not this activation is similar 
to the above mentioned T-cell-induced macrophage 
activation is not clear. In either case, the overall effect 
of macrophage activation is an enhanced capacity of 
the cell to inactivate and degrade phagocytosed micro- 
organisms as well as cellular material including tumor 
cells (Adams and Hamilton 1992, Crawford et al. 
1994). In addition, a plethora of cytokines that are 
released at the site of infection upregulate xpression 
of MHC class II molecules and can also activate the T 
and B lymphocytes of the acquired immune system, 
thereby contributing to elimination of the infection. 
The cell biological processes responsible for and 
accompanying macrophage activation are still poorly 
understood. Most likely, multiple signals are involved 
in generating an "activated macrophage", and which 
signals dominate may depend on the location of the 
macrophage within the organism, the type of infection, 
and the presence of accessory cells that can secrete 
activating cytokines. Whereas virtually every known 
cytokine has been implicated in macrophage activa- 
tion, the best studied is gamma interferon (IFN-7). 
INF-7, when added to macrophages, upregulates MHC 
molecules, enhances phagocytosis and for some 
microorganisms results in an increased killing (Fowles 
et al. 1973). IFN-ydoes not fully activate macrophages, 
but rather induces a "primed" state (Adams and 
Hamilton 1992). Primed macrophages can then be 
fully activated by other compounds such as low 
amounts of lipopolysaccharide (LPS, also called endo- 
toxin), a glycolipid that is a component of the gram- 
negative bacterial cell wall (Adams and Hamilton 
1984). LPS binds to a macrophage cell surface recep- 
tor and thereby activates a signal transduction cas- 
cade resulting in the secretion of various cytokines 
that together contribute to the activation of the 
macrophage. Very recently, the receptor that is acti- 
vated upon LPS addition to macrophages has been 
determined to be a member of the Toll-like receptors 
(TLR) (Kirschning et al. 1998, Poltorak et al. 1998, 
Yang et al. 1998). These receptors bear homology to 
Toll, a molecule conserved from plants to mammals, 
and are thought o play a role in host defense (Fearon 
1997, Lemaitre et al. 1996, Medzhitov et al. 1997). 
LPS does not bind directly to Toll-like receptors but 
does so via the GPI(glycosyl phosphatidylinositol)- 
linked cell surface molecule CD14 (Gerard 1998). LPS 
that is shed from the bacteria within a host usually 
aggregates, and these aggregates bind to a serum 
protein called LPS-binding protein (LBP). LBP breaks 
down these aggregates allowing the binding of LPS 
to the cell surface molecule CD14. But because CD14 
lacks a transmembrane and cytosolic domain (being 
a GPI-linked molecule), it cannot directly transmit 
activation signals to the cytosol. The molecules that 
seem to be responsible for transmitting signals are 
the aforementioned TLRs, which are activated upon 
engagement by LPS in the presence of LBP and CD14 
(Gerard 1998; Medzhitov and Janeway 1997, 1998; 
Medzhitov et al. 1997; Yang et al. 1998). 
Apart from LPS, virtually every known cytokine has 
been shown to act in macrophage activation, alone or 
in concert with other reagents, and to varying effi- 
ciency with regard to microbicidal activity against 
different microorganisms (Crawford etal. 1994). 
However, it is currently unknown which components 
induce activation in vivo. The availability of mice 
lacking one or several cytokines and/or cell surface 
receptor molecules may help to elucidate the precise 
molecules involved. 
Macrophage activation leads to several cellular 
processes that aid in the elimination of the microor- 
ganisms. First, activated macrophages upregulate their 
phagocytic apacity. Second, the capacity of macro- 
phages to kill the phagocytosed microbes is drastically 
enhanced, through the upregulation of radical forma- 
tion in the phagosome on the one hand, and through 
the stimulation of phagosome-lysosome fusion on the 
other. Third, activated macrophages upregulate the 
expression of MHC class II molecules, allowing the 
adaptive immune system to contribute to the elim- 
ination of the invading microorganisms. 
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Evasion of host defense mechanism 
The microbicidal activities of macrophages, together 
with the capacity of the adaptive immune system to 
generate a strong antibody-mediated response, is 
usually sufficient o eradicate any microbe that has 
invaded the host organism. However, many microor- 
ganisms have coevolved with their eukaryotic host for 
a considerable time, and it is therefore not surprising 
that various microbes have developed mechanisms 
allowing them to circumvent host defense responses. 
In fact, one reason why some microbes have become 
pathogenic is precisely because they have evolved 
ways to survive and replicate within their mammalian 
host. Many pathogens do this by finding a suitable 
site within the host cell where they can thrive and at 
the same time circumvent host defense mechanisms 
(Falkow et al. 1992, Galan and Bliska 1996, Pieters 
1999b, Small et al. 1994). 
Subversion of phagocytos& by mycobacteria 
One particularly successful example of pathogen-host 
interaction is provided by the interaction of mycobac- 
teria with macrophages. Macrophages, as mentioned, 
are among the most professional phagocytes, which, 
in addition, can present antigenic peptides bound to 
MHC class II molecules to T lymphocytes (Silverstein 
1995, Unanue 1984). Indeed, macrophages do ingest 
mycobacteria and are also able to stimulate T lym- 
phocytes to a certain degree (de Chastellier et al. 1995, 
Inaba et al. 1993, Kaufmann 1993). But at the same 
time, mycobacteria h ve the capacity to resist destruc- 
tion by the macrophage, and as a result, these bacilli 
can survive and even replicate within the macrophage 
(Russell 1995). In doing so, mycobacteria can also 
become sequestered from the activity of T lympho- 
cytes, thus allowing these bacteria to escape immune 
defense mechanisms (Pancholi etal. 1993). These 
highly efficient escape mechanisms are believed to be 
involved in the pathogenicity of mycobacterial in- 
fections, which include tuberculosis, leprosy, as well as 
various opportunistic nfections (Bloom 1992, Murray 
and Salomon 1998). 
The mechanism by which mycobacteria resist 
destruction i the macrophage is linked to the capac- 
ity of these bacteria to inhibit phagosome-lysosome 
fusion (Armstrong and D'Arcy Hart 1971, Barker 
et al. 1997, Hasan et al. 1997). The molecular basis of 
this capacity has however remained unclear until 
recently, when it was demonstrated that within macro- 
phages, living mycobacteria recruit and retain a host 
protein, TACO (tryptophane aspartate-containing 
coat protein). As a result of this retention, the myco- 
bacterial phagosome is unable to fuse with or mature 
into lysosomes (Ferrari et al. 1999). In contrast, killed 
mycobacteria c nnot retain TACO and are therefore 
rapidly delivered to lysosomes followed by their 
degradation (see Fig. 2). Although the normal cellular 
function of TACO is still unknown, it might be 
involved in generating the forces that are needed to 
internalize large particles, including (living) bacteria. 
Upon phagocytosis, TACO forms a coat around the 
phagosome that has to be released to allow the fusion 
machinery to be recruited at the phagosomal mem- 
brane. Apparently, during the long-standing coevolu- 
Fig. 2. Evasion of macrophage host defense 
mechanisms by mycobacteria. Phagocytosis 
of mycobacteria (blue) into macrophages 
triggers the recruitment of TACO (yellow) 
around the nascent phagosome. In case of 
killed mycobacteria, the TACO coat has to 
be removed in order to allow delivery of the 
phagosomal content to lysosomes, where 
this material is degraded. In contrast, liv- 
ing mycobacteria that have entered the 
macrophage have somehow gained the ca- 
pacity to retain TACO at the phagosomal 
membrane, thereby preventing their deliv- 
ery to lysosomes and atlowing them to 
survive within the phagosome 
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tion of mycobacter ia with their host organisms, they 
have managed to actively recruit and retain TACO for 
their own benefit. 
By hiding inside macrophage phagosomes, myco- 
bacteria not only manage to circumvent the normal  
bactericidal mechanisms of these cells but, in addition, 
become invisible for other host defense mechanisms, 
such as the generat ion of ant imycobacter ial  antibodies 
that of course can only deal with extracellularly resid- 
ing antigens. In addition, because of the nondegrada-  
tive env i ronment  of the mycobacterial  phagosome, 
antigenic fragments cannot  be generated, prevent ing 
the generat ion of a proper MHC-dependent  T cell 
response (Pancholi  et al. 1993). 
The strategy employed by mycobacter ia to circum- 
vent destruction within macrophages i  once more an 
intr iguing example of how microbes have evolved in 
concert with their host organisms. In addition, knowl- 
edge of these strategies might allow the design of 
rat ional agents to combat pathogens that escape the 
normal  immune defense reactions. 
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